Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited

Jan-Inge Henter, Elena Sieni, Julia Eriksson, Elisabet Bergsten, Ida Hed Myrberg, Scott W. Canna, Maria Luisa Coniglio, Randy Q. Cron, Kate F. Kernan, Ashish R. Kumar, Kai Lehmberg, Francesca Minoia, Ahmed Naqvi, Angelo Ravelli, Yong-Min Tang, Matteo Bottai, Yenan T. Bryceson, AnnaCarin Horne, Michael B. Jordan

Blood (2024) 144 (22): 2308–2318.

https://doi.org/10.1182/blood.2024025077

Published: 2024

Includes: Supplemental data

Journal Articles

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Blood (2024) 144 (8): 873–887.

https://doi.org/10.1182/blood.2024024499

Published: 2024

Includes: Supplemental data

Journal Articles

Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

Blood (2024) 143 (10): 872–881.

https://doi.org/10.1182/blood.2023022281

Published: 2024

Includes: Supplemental data

Journal Articles

Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival

Alexandra Löfstedt, Martin Jädersten, Marie Meeths, Jan-Inge Henter

Blood (2024) 143 (3): 233–242.

https://doi.org/10.1182/blood.2023020715

Published: 2024

Includes: Supplemental data

Journal Articles

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

Paul La Rosée, AnnaCarin Horne, Melissa Hines, Tatiana von Bahr Greenwood, Rafal Machowicz, Nancy Berliner, Sebastian Birndt, Juana Gil-Herrera, Michael Girschikofsky, Michael B. Jordan, Ashish Kumar, Jan A. M. van Laar, Gunnar Lachmann, Kim E. Nichols, Athimalaipet V. Ramanan, Yini Wang, Zhao Wang, Gritta Janka, Jan-Inge Henter

Blood (2019) 133 (23): 2465–2477.

https://doi.org/10.1182/blood.2018894618

Published: 2019

Journal Articles

Co-Expression of CD56 and Production of Transforming Growth Factor Beta By Foxp3 Regulatory T Cells from Langerhans Cell Histiocytosis Lesions

Jenee Mitchell, BSc, Egle Kvedaraite, Tatiana von Bahr Greenwood, Jan-Inge Henter, MD PhD, Daniel G Pellicci, Stuart P Berzins, George Kannourakis, MD PhD

Blood (2018) 132 (Supplement 1): 3702.

https://doi.org/10.1182/blood-2018-99-114268

Published: 2018

Journal Articles

Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

Elisabet Bergsten, AnnaCarin Horne, Maurizio Aricó, Itziar Astigarraga, R. Maarten Egeler, Alexandra H. Filipovich, Eiichi Ishii, Gritta Janka, Stephan Ladisch, Kai Lehmberg, Kenneth L. McClain, Milen Minkov, Scott Montgomery, Vasanta Nanduri, Diego Rosso, Jan-Inge Henter

Blood (2017) 130 (25): 2728–2738.

https://doi.org/10.1182/blood-2017-06-788349

Published: 2017

Journal Articles

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms

Blood (2017) 129 (16): 2266–2279.

https://doi.org/10.1182/blood-2016-10-743302

Published: 2017

Includes: Supplemental data

Journal Articles

Cytopenia, Predisposition to Myelodysplastic Syndrome, Immunodeficiency, and Neurological Disease Caused By Gain-of-Function SAMD9L Mutations Is Frequently Ameliorated By Hematopoietic Revertant Mosaicism

Blood (2016) 128 (22): 4299.

https://doi.org/10.1182/blood.V128.22.4299.4299

Published: 2016

Journal Articles

Adsorptive depletion of blood monocytes reduces the levels of circulating interleukin-17A in Langerhans cell histiocytosis

Magda Lourda, Selma Olsson-Åkefeldt, Désirée Gavhed, Ulla Axdorph Nygell, Gösta Berlin, Evaldas Laurencikas, Tatiana von Bahr Greenwood, Mattias Svensson, Jan-Inge Henter

Blood (2016) 128 (9): 1302–1305.

https://doi.org/10.1182/blood-2016-03-708107

Published: 2016

Includes: Supplemental data

Journal Articles

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Blood (2016) 127 (25): 3281–3290.

https://doi.org/10.1182/blood-2015-12-684498

Published: 2016

Includes: Supplemental data

Journal Articles

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Blood (2016) 127 (22): 2672–2681.

https://doi.org/10.1182/blood-2016-01-690636

Published: 2016

Includes: Supplemental data

Journal Articles

Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study

Jean Donadieu, Frederic Bernard, Max van Noesel, Mohamed Barkaoui, Odile Bardet, Rosella Mura, Maurizio Arico, Christophe Piguet, Virginie Gandemer, Corinne Armari Alla, Niels Clausen, Eric Jeziorski, Anne Lambilliote, Sheila Weitzman, Jan Inge Henter, Cor Van Den Bos, the Salvage Group of the Histiocyte Society

Blood (2015) 126 (12): 1415–1423.

https://doi.org/10.1182/blood-2015-03-635151

Published: 2015

Includes: Supplemental data

Journal Articles

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

Helmut Gadner, Milen Minkov, Nicole Grois, Ulrike Pötschger, Elfriede Thiem, Maurizio Aricò, Itziar Astigarraga, Jorge Braier, Jean Donadieu, Jan-Inge Henter, Gritta Janka-Schaub, Kenneth L. McClain, Sheila Weitzman, Kevin Windebank, Stephan Ladisch

Blood (2013) 121 (25): 5006–5014.

https://doi.org/10.1182/blood-2012-09-455774

Published: 2013

Journal Articles

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production

Blood (2013) 121 (8): 1345–1356.

https://doi.org/10.1182/blood-2012-07-442558

Published: 2013

Includes: Supplemental data

Journal Articles

A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes

Blood (2012) 119 (12): 2754–2763.

https://doi.org/10.1182/blood-2011-08-374199

Published: 2012

Includes: Supplemental data

Journal Articles

Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D

Blood (2011) 118 (22): 5783–5793.

https://doi.org/10.1182/blood-2011-07-369090

Published: 2011

Includes: Supplemental data

Journal Articles

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Helena Trottestam, AnnaCarin Horne, Maurizio Aricò, R. Maarten Egeler, Alexandra H. Filipovich, Helmut Gadner, Shinsaku Imashuku, Stephan Ladisch, David Webb, Gritta Janka, Jan-Inge Henter, for the Histiocyte Society

Blood (2011) 118 (17): 4577–4584.

https://doi.org/10.1182/blood-2011-06-356261

Published: 2011

Includes: Supplemental data

Journal Articles

Proteasome Inhibitor Bortezomib Disrupts Tumor Necrosis Factor-Related Apoptosis-Inducing ligand (TRAIL) Expression and Natural Killer (NK) Cell Killing of TRAIL Receptor-Positive Multiple Myeloma Cells

Xiaoli Feng, M.D., Jie Yan, MD., Yibiao Wang, MD., Juleen R. Zierath, Ph.D, Magnus Nordenskjöld, MD., Ph.D, Jan-Inge Henter, MD, PhD, Bengt Fadeel, MD, PhD, Chengyun Zheng, MD, PhD

Blood (2010) 116 (21): 5021.

https://doi.org/10.1182/blood.V116.21.5021.5021

Published: 2010

Journal Articles

Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2

Marie Meeths, Miriam Entesarian, Waleed Al-Herz, Samuel C. C. Chiang, Stephanie M. Wood, Wafa Al-Ateeqi, Francisco Almazan, Jaap J. Boelens, Henrik Hasle, Marianne Ifversen, Bendik Lund, J. Merlijn van den Berg, Britt Gustafsson, Hans Hjelmqvist, Magnus Nordenskjöld, Yenan T. Bryceson, Jan-Inge Henter

Blood (2010) 116 (15): 2635–2643.

https://doi.org/10.1182/blood-2010-05-282541

Published: 2010

NARROW

Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited

Efficacy of T-cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis

Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation

Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

Co-Expression of CD56 and Production of Transforming Growth Factor Beta By Foxp3 Regulatory T Cells from Langerhans Cell Histiocytosis Lesions

Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms

Cytopenia, Predisposition to Myelodysplastic Syndrome, Immunodeficiency, and Neurological Disease Caused By Gain-of-Function SAMD9L Mutations Is Frequently Ameliorated By Hematopoietic Revertant Mosaicism

Adsorptive depletion of blood monocytes reduces the levels of circulating interleukin-17A in Langerhans cell histiocytosis

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study

Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production

A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes

Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D

Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol

Proteasome Inhibitor Bortezomib Disrupts Tumor Necrosis Factor-Related Apoptosis-Inducing ligand (TRAIL) Expression and Natural Killer (NK) Cell Killing of TRAIL Receptor-Positive Multiple Myeloma Cells

Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only